Stockscreener 앱 받기
1.475
0.42%
0.005
전일 마감가:
$1.47
열려 있는:
$1.61
하루 거래량:
345.41K
Relative Volume:
0.38
시가총액:
$170.58M
수익:
$232.79M
순이익/손실:
$-88.69M
주가수익비율:
-3.3379
EPS:
-0.4419
순현금흐름:
-
1주 성능:
-7.16%
1개월 성능:
-18.89%
6개월 성능:
-64.94%
1년 성능:
+0.00%
1일 변동 폭
$1.475
$1.67
1주일 범위
$1.46
$1.67
52주 변동 폭
$1.46
$5.19
Novabridge Biosciences Adr Stock (NBP) Company Profile
Compare NBP vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
1.475 | 170.00M | 232.79M | -88.69M | 0 | -0.4419 |
VRTX
Vertex Pharmaceuticals Inc
|
449.61 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
611.27 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.41 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.76 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
155.40 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-06 | 재개 | H.C. Wainwright | Buy |
| 2025-10-03 | 개시 | Leerink Partners | Outperform |
| 2025-09-09 | 개시 | BTIG Research | Buy |
| 2021-12-09 | 개시 | Siebert Williams Shank | Buy |
| 2021-06-02 | 개시 | Daiwa Securities | Buy |
| 2021-03-15 | 개시 | Needham | Buy |
| 2021-03-03 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-25 | 개시 | Piper Sandler | Overweight |
| 2020-12-07 | 개시 | H.C. Wainwright | Buy |
| 2020-07-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-02-12 | 개시 | China Renaissance | Buy |
| 2020-02-11 | 개시 | Jefferies | Buy |
모두보기
Novabridge Biosciences Adr 주식(NBP)의 최신 뉴스
Number of shareholders of NovaBridge Biosciences Sponsored ADR – GETTEX:0VY - TradingView
NovaBridge Biosciences SVP Claire Xu sells $13,766 in shares By Investing.com - Investing.com India
NovaBridge Biosciences SVP Claire Xu sells $13,766 in shares - Investing.com
Sean Cao, NovaBridge Biosciences chief BD officer, sells $42,584 in shares - Investing.com
TradingKey - TradingKey
Alpha Buying: Insider Conviction in High-Risk Biotech - Sahm
NovaBridge Biosciences president buys $577,300 in company shares By Investing.com - Investing.com India
NovaBridge Biosciences president buys $577,300 in company shares - Investing.com
NovaBridge appoints Mark Hagler as president, chief commercial officer - Investing.com
NovaBridge Biosciences (NASDAQ: NBP) posts 2025 loss, extends cash runway to 2028 - Stock Titan
H.C. Wainwright reiterates NovaBridge stock rating on FDA feedback - Investing.com India
NovaBridge gets FDA nod for accelerated approval path for givastomig - Investing.com
NovaBridge reports positive Phase 2a data for eye disease drug - Investing.com
NovaBridge to present Phase 2a data for wet AMD treatment VIS-101 - Investing.com India
NovaBridge enrolls first patient in phase 2 gastric cancer study By Investing.com - Investing.com India
NovaBridge enrolls first patient in phase 2 gastric cancer study - Investing.com
NovaBridge Biosciences stock price target raised to $9 by H.C. Wainwright - Investing.com Nigeria
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
NovaBridge chairman to purchase up to $5 million in company shares By Investing.com - Investing.com Nigeria
NovaBridge chairman to purchase up to $5 million in company shares - Investing.com
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target By Investing.com - Investing.com South Africa
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target - Investing.com Nigeria
NovaBridge stock soars after positive gastric cancer drug results - Investing.com
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 - GlobeNewswire Inc.
Understanding RRC’s financial ratios: A beginner’s guide - uspostnews.com
NovaBridge Biosciences. ADR’s results are impressive - uspostnews.com
NovaBridge to present extended dosing data for cancer drug ragistomig - Investing.com
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating - Investing.com
What is the current Price Target and Forecast for NovaBridge Biosciences (NBP) - Zacks Investment Research
NovaBridge Biosciences Share Price ADS SPON - Hargreaves Lansdown
NovaBridge Biosciences (0VY.F) stock price, news, quote and history - Yahoo Finance Singapore
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
What date does NovaBridge Biosciences's (NBP) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
NBP Stock Price | Analyst Target 9.00 & Consensus - eToro
symbol__ Stock Quote Price and Forecast - CNN
NovaBridge Biosciences Sponsored ADR Earnings and Revenue – NASDAQ:NBP - TradingView — Track All Markets
IMAB Stock Price, Quote & Chart | I-MAB-SPONSORED ADR (NASDAQ:IMAB) - ChartMill
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
IMAB SEC FilingsI-Mab 10-K, 10-Q, 8-K Forms - Stock Titan
IMAB Stock Price, News & Analysis - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Most VolatileStock ScreenerNews - Finviz
Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar
10 of the Cheapest Stocks of 2022 - Morningstar
Invesco NASDAQ Future Gen 200 ETF Holdings - Quiver Quantitative
The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar
New 5-Star Stocks - Morningstar
Novabridge Biosciences Adr (NBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Novabridge Biosciences Adr 주식 (NBP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cao Sean Wuxiong | See Remarks |
May 14 '26 |
Sale |
1.99 |
21,399 |
42,584 |
35,073 |
1.61%
자본화:
|
볼륨(24시간):